V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240006886 | 240010426 | 1.67 | 71.4 | Palliative (P) | 2015-02-05 | 2015-02-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240031880 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006887 | 240004328 | 0 | 87.5 | Curative (C) | 2013-12-16 | 2013-12-18 | Trial Unspecified | N | N | 240031913 | TRIAL |
| 240006888 | 240004329 | 1.85 | 72.5 | Palliative (P) | 2017-09-06 | 2017-09-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240031916 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006889 | 240004330 | 1.72 | 96.6 | Curative (C) | null | 2015-07-22 | null | Y | N | 240031919 | NOT MATCHED |
| 240006890 | 240010427 | 1.56 | 64.2 | Palliative (P) | 2013-06-13 | 2013-06-13 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240031921 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006891 | 240013456 | 0 | 64 | Curative (C) | 2015-10-03 | 2015-10-22 | Carboplatin AUC 2 - 5 | 02 | N | 240031923 | CARBOPLATIN |
| 240006892 | 240004331 | 1.57 | 62.5 | Palliative (P) | 2015-11-22 | 2015-11-25 | CYCLOPHOSPHAMIDE + GEMCITABINE + METHOTREXATE | N | N | 240031924 | NOT MATCHED |
| 240006893 | 240004331 | 1.68 | 70 | Disease modification (D) | 2014-01-17 | 2014-01-17 | Hydroxycarbamide | Y | N | 240031924 | HYDROXYCARBAMIDE |
| 240006894 | 240004332 | 1.69 | 53.9 | Palliative (P) | 2015-05-27 | 2015-05-28 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240031937 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006895 | 240010429 | 0 | 69.3 | Curative (C) | 2015-11-19 | 2015-11-25 | INTERLACE TRIAL | Y | N | 240031941 | INTERLACE TRIAL |
| 240006896 | 240010429 | 1.56 | 69 | null | 2017-04-08 | 2017-04-29 | Chlorambucil | N | null | 240031941 | CHLORAMBUCIL |
| 240006897 | 240010429 | 0 | 68.9 | null | null | 2014-10-14 | Bendamustine +/- Prednisolone | N | N | 240031941 | BENDAMUSTINE |
| 240006898 | 240010429 | 1.55 | 53.9 | Disease modification (D) | 2016-01-04 | 2016-01-04 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240031941 | CHLORAMBUCIL + RITUXIMAB |
| 240006899 | 240016003 | 1.51 | 99.9 | Palliative (P) | null | 2017-03-12 | Chlorambucil | N | N | 240031945 | CHLORAMBUCIL |
| 240006900 | 240016195 | 1.63 | 71.2 | Palliative (P) | 2014-05-01 | 2014-05-31 | Bevacizumab+Carbo+Pacliaxel | Y | Y | 240031947 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006901 | 240004333 | 1.84 | 52.4 | Curative (C) | 2014-02-21 | 2014-02-24 | null | 02 | N | 240031950 | NOT MATCHED |
| 240006902 | 240004334 | 1.62 | 62 | Curative (C) | 2013-07-16 | 2013-07-19 | Trial Unspecified | 01 | N | 240031952 | TRIAL |
| 240006903 | 240004335 | 1.72 | 45.2 | Palliative (P) | 2014-12-13 | 2014-12-13 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240031958 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006904 | 240010430 | null | 70 | Palliative (P) | 2015-11-20 | 2016-01-15 | Chlorambucil | N | N | 240031959 | CHLORAMBUCIL |
| 240006905 | 240004336 | 1.68 | null | Curative (C) | 2016-11-26 | 2016-12-08 | CYTARABINE + DAUNORUBICIN | N | N | 240031961 | DA |
| 240006906 | 240004337 | null | 60 | Disease modification (D) | null | 2016-11-13 | R Chlorambucil | 02 | N | 240031965 | CHLORAMBUCIL + RITUXIMAB |
| 240006907 | 240004338 | 1.74 | 61.4 | Neo-adjuvant (N) | null | 2015-02-09 | Carboplatin AUC 6 - 10 | N | N | 240031968 | CARBOPLATIN |
| 240006908 | 240004339 | 1.73 | 65 | Palliative (P) | 2013-09-22 | 2013-09-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240031969 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006909 | 240004339 | null | 56.5 | null | 2014-04-15 | 2014-04-15 | null | null | null | 240031969 | NOT MATCHED |
| 240006910 | 240013458 | 1.67 | 88 | Palliative (P) | 2015-02-28 | 2015-03-28 | Carboplatin AUC 2 - 5 | 2 | N | 240031971 | CARBOPLATIN |
| 240006911 | 240013458 | null | null | Palliative (P) | 2016-03-24 | 2016-05-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240031971 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006912 | 240013458 | 1.68 | 130.4 | Curative (C) | 2017-04-30 | 2017-04-30 | INTERLACE TRIAL | N | N | 240031971 | INTERLACE TRIAL |
| 240006913 | 240013458 | null | 74 | Adjuvant (A) | 2018-04-03 | 2018-04-10 | R Chlorambucil | 02 | N | 240031971 | CHLORAMBUCIL + RITUXIMAB |
| 240006914 | 240013458 | 1.75 | 70.5 | Palliative (P) | 2016-01-09 | 2016-01-13 | Bevacizumab+Carbo+Pacliaxel | N | N | 240031971 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006915 | 240004340 | null | 101.5 | Palliative (P) | 2016-09-19 | 2016-10-10 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240031988 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006916 | 240004341 | 1.71 | 96.8 | Curative (C) | 2017-09-12 | 2017-09-20 | null | 2 | N | 240031990 | NOT MATCHED |
| 240006917 | 240004342 | 1.85 | 0 | Palliative (P) | null | 2013-09-06 | Carboplatin AUC 6 - 10 | N | N | 240031991 | CARBOPLATIN |
| 240006918 | 240010432 | 0 | 74 | null | 2013-05-21 | 2013-05-27 | INTERLACE TRIAL | 02 | N | 240031992 | INTERLACE TRIAL |
| 240006919 | 240004343 | 0 | 74 | Adjuvant (A) | 2014-05-11 | 2014-05-15 | Bevacizumab+Carbo+Pacliaxel | N | N | 240031993 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006920 | 240004343 | 1.8 | 65.1 | Disease modification (D) | 2014-12-13 | 2014-12-13 | Trial Unspecified | N | N | 240031993 | TRIAL |
| 240006921 | 240004344 | 1.72 | 108.4 | null | null | 2015-07-21 | Bendamustine +/- Prednisolone | 02 | N | 240031996 | BENDAMUSTINE |
| 240006922 | 240004344 | 1.66 | 100.6 | Palliative (P) | 2017-01-08 | 2017-01-08 | Chlorambucil | 2 | N | 240031996 | CHLORAMBUCIL |
| 240006923 | 240004345 | 1.6 | 65 | Palliative (P) | 2016-06-15 | 2016-06-15 | Carboplatin + Etoposide iv&po | 2 | N | 240032002 | CARBOPLATIN + ETOPOSIDE |
| 240006924 | 240004346 | 1.79 | 92.2 | Palliative (P) | 2014-06-03 | 2014-06-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240032005 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006925 | 240010435 | 0 | null | Curative (C) | 2016-03-04 | 2016-04-01 | INTERLACE TRIAL | N | N | 240032007 | INTERLACE TRIAL |
| 240006926 | 240004347 | null | null | Palliative (P) | 2017-10-27 | 2017-10-27 | Chlorambucil | null | N | 240032012 | CHLORAMBUCIL |
| 240006927 | 240010436 | 1.55 | 66 | Palliative (P) | 2013-10-12 | 2013-10-12 | Hydroxycarbamide | N | N | 240032013 | HYDROXYCARBAMIDE |
| 240006928 | 240004348 | 1.57 | 0 | Palliative (P) | 2013-11-27 | 2013-12-03 | Chlorambucil | N | N | 240032015 | CHLORAMBUCIL |
| 240006929 | 240004348 | 1.59 | 83.65 | Palliative (P) | 2015-11-14 | 2015-11-26 | CHLORAMBUCIL + RITUXIMAB | Y | N | 240032015 | CHLORAMBUCIL + RITUXIMAB |
| 240006930 | 240004349 | 1.61 | 70 | Neo-adjuvant (N) | null | 2017-12-16 | null | N | N | 240032023 | NOT MATCHED |
| 240006931 | 240004349 | 1.87 | 83 | Palliative (P) | 2018-03-12 | 2018-03-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | null | 240032023 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006932 | 240004350 | 1.66 | 57 | Not known (9) | 2014-02-11 | 2014-02-14 | Trial Unspecified | N | N | 240032027 | TRIAL |
| 240006933 | 240004351 | null | 98.6 | Disease modification (D) | null | 2016-09-28 | CHLORAMBUCIL + RITUXIMAB | Y | null | 240032030 | CHLORAMBUCIL + RITUXIMAB |
| 240006934 | 240010439 | 1.6 | 88.5 | Palliative (P) | 2017-09-15 | 2017-10-04 | R Chlorambucil | 2 | N | 240032036 | CHLORAMBUCIL + RITUXIMAB |
| 240006935 | 240010439 | 1.56 | null | null | 2017-02-05 | 2017-02-05 | R Chlorambucil | Y | N | 240032036 | CHLORAMBUCIL + RITUXIMAB |